University of California at Los Angeles Div. of Hematology/Oncology — Los Angeles, California

University of California at Los Angeles Div. of Hematology/Oncology is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of California at Los Angeles Div. of Hematology/Oncology has participated in 1 clinical trials.

Therapeutic areas: Advanced and Selected Solid Tumors.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California at Los Angeles Div. of Hematology/Oncology?

University of California at Los Angeles Div. of Hematology/Oncology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California at Los Angeles Div. of Hematology/Oncology conducted?

University of California at Los Angeles Div. of Hematology/Oncology has 1 clinical trials on record. Their work covers Advanced and Selected Solid Tumors.

Is University of California at Los Angeles Div. of Hematology/Oncology accredited by Crixeo Health?

University of California at Los Angeles Div. of Hematology/Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California at Los Angeles Div. of Hematology/Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.